612487-28-2

Basic information

• Product Name: 1-(2-CHLOROISONICOTINOYL)-4-METHYLPIPERAZINE
• Synonyms: 1-(2-CHLOROISONICOTINOYL)-4-METHYLPIPERAZINE;1-(2-chloroisonicotinoyl)-4-methylpiperazine(SALTDATA: HCl)
• CAS NO: 612487-28-2
• Molecular Formula: C11H14ClN3O
• Molecular Weight: 239.7
• Mol File: 612487-28-2.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 395.9°C at 760 mmHg
• Flash Point: 193.2°C
• Appearance: /
• Density: 1.256g/cm³
• Vapor Pressure: 1.78E-06mmHg at 25°C
• Refractive Index: 1.573
• PKA: 6.42±0.10(Predicted)
• CAS DataBase Reference: 1-(2-CHLOROISONICOTINOYL)-4-METHYLPIPERAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2-CHLOROISONICOTINOYL)-4-METHYLPIPERAZINE(612487-28-2)
• EPA Substance Registry System: 1-(2-CHLOROISONICOTINOYL)-4-METHYLPIPERAZINE(612487-28-2)

Safety Data

• Hazardous Substances Data: 612487-28-2(Hazardous Substances Data)

Usage

Description

1-(2-Chloroisonicotinoyl)-4-methylpiperazine, also known as 2-Cl-Nic-4-MEP, is a chemical compound derived from 2-chloronicotinic acid and 4-methylpiperazine. It has demonstrated potential in medicinal chemistry, particularly as an antipsychotic and anticonvulsant agent. Its ability to bind to serotonin and dopamine receptors in the brain, which are involved in mood and behavior regulation, makes it a promising candidate for the treatment of various neurological disorders.

Uses

Used in Pharmaceutical Industry:
1-(2-Chloroisonicotinoyl)-4-methylpiperazine is used as an antipsychotic agent for its potential to regulate mood and behavior by binding to serotonin and dopamine receptors in the brain. This makes it a candidate for the treatment of psychiatric disorders.
1-(2-Chloroisonicotinoyl)-4-methylpiperazine is also used as an anticonvulsant agent for its potential to help control seizures and other neurological conditions by modulating the activity of neurotransmitter receptors.
Research is ongoing to further explore the therapeutic applications of 1-(2-Chloroisonicotinoyl)-4-methylpiperazine in the treatment of various neurological disorders, indicating its potential for future use in medical treatments.

InChI:InChI=1/C11H14ClN3O/c1-14-4-6-15(7-5-14)11(16)9-2-3-13-10(12)8-9/h2-3,8H,4-7H2,1H3